TELO Rises on Promising Telomir-1 Preclinical Results
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) is among the 10 Best Growth Stocks Under $100 to Buy Now. On Wednesday, Telomir Pharmaceuticals, Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 166,975 | $222,077 | -25% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.00 | 49,000 | $343,000.00 | 1,902,659 | 2024-02-13 | Filing | |
| $7.00 | 40,000 | $280,000.00 | 1,365,646 | 2024-02-13 | Filing | |
| $7.00 | 49,000 | $343,000.00 | 5,455,431 | 2024-02-13 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.20 | 200 | $1,240.00 | 29,600 | 2024-08-19 | Filing | |
| $6.01 | 200 | $1,202.00 | 29,600 | 2024-08-19 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,137,466 | $1,512,830 | 0% | |
| 2. | 285,454 | $379,654 | 0% | |
| 3. | 223,549 | $297,459 | 0% | |
| 4. | 58,600 | $77,938 | 0% | |
| 5. | 51,454 | $68,434 | 0% |